Table 2. Summary of treatment outcome by State and drug.

State	Treatment Outcome	Drug			Total
		AA	AL	DHP
Enugu	Number of samples		50	50	100
	ETF		0	0	0
	LCF		0	0	0
	LPF		11	2	14
	ACPR_u		39	48	87
	ACPR_c		49	50	99
	%ACPR_c		98	100	99
Kano	Number of samples	50	50		100
	ETF	0	0		0
	LCF	0	0		0
	LPF	2	9		11
	ACPR_u	48	41		89
	ACPR_c	50	50		100
	%ACPR_c	100	100		100
Plateau	Number of samples	50	50		100
	ETF	0	0		0
	LCF	0	0		0
	LPF	1	7		8
	ACPR_u	49	43		92
	ACPR_c	50	50		100
	%ACPR_c	100	100		100
Total	Number of samples	100	150	50	300
	ETF	0	0	0	0
	LCF	0	0	0	0
	LPF	3	27	2	32
	ACPR_u	97	123	47	267
	ACPR_c	100	149	50	299
	%ACPR_c	100	99.3	100	99.7

Crude ACPR (ACPR_u); PCR-corrected ACPR (ACPR_c).

WHO protocol for parasite genotyping to differentiate recrudescence from new infections available at http://whqlibdoc.who.int/publications/2008/9789241596305_eng.pdf.